Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 188 #1
TickerCDTI [NASD]
CompanyClean Diesel Technologies Inc.
CountryUSA
IndustryPollution & Treatment Controls
Market Cap48.56MEPS (ttm)-0.84
P/E-EPS this Y38.80%
Forward P/E-EPS next Y31.50%
PEG-EPS past 5Y34.70%
P/S0.89EPS next 5Y-
P/B5.01EPS Q/Q47.40%
Dividend-Sales Q/Q0.00%
Insider Own0.70%Inst Own9.50%
Insider Trans58.25%Inst Trans-0.34%
Short Float4.02%EarningsNov 07/b
Analyst Recom2.00Target Price3.75
Avg Volume671.69K52W Range1.33 - 7.39
30-Oct-14 11:15PMCDTI: Patent granted for zero platinum group and zero rare earth metal automobile catalysts. Zacks Small Cap Research
30-Oct-14 01:35PMAre Two Patents Worth 70% More? at 24/7 Wall St.
30-Oct-14 11:32AMClean Diesel Technologies (CDTI) Stock Surges After Receipt of Two U.S. Patents at TheStreet
30-Oct-14 08:34AM8:34 am Clean Diesel Technologies unveils breakthrough clean air technology; eliminates need for expensive platinum group and rare earth metals Briefing.com
30-Oct-14 08:30AMCDTi Unveils Breakthrough Clean Air Technology GlobeNewswire
23-Oct-14 09:00AMCDTI: Concentrating on core competencies by divesting Nevada operations. Preliminary 3Q revenue and operating income announced. Zacks Small Cap Research
21-Oct-14 08:51AMCLEAN DIESEL TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Materi EDGAR Online
21-Oct-14 08:00AMCDTi Executes Strategy to Focus Business Through Sale of Standard Exhaust and Specialty Parts Asset GlobeNewswire
10-Oct-14 08:32AMZacks Rank #1 Additions for Friday Zacks
30-Sep-14 09:00AMCLEAN DIESEL TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Clean Diesel Technologies, Inc. manufactures and distributes light duty vehicle catalysts and heavy duty diesel emissions control systems and products to automakers, integrators, and retrofitters in the United States, Canada, Sweden, and the United Kingdom. The company operates in two divisions, Heavy Duty Diesel Systems and Catalyst. The Heavy Duty Diesel Systems division designs and manufactures verified exhaust emissions control solutions. This division's products include diesel oxidation catalysts, diesel particulate filters, closed crankcase ventilation systems, and alternative fuel products. It also manufactures various exhaust accessories and specialty parts, including connectors, elbows, mounting brackets, clamps, exhaust stacks and guards, and intake air components; and manufactures and distributes diesel and natural gas exhaust and intake parts, as well as fenders, catalytic converter components, numerous brackets, guards, and clamps for mounting and sealing components. In addition, this division produces exhaust and intake components for racing enthusiasts; and manufactures intake and exhaust components for off-road and mining equipment, as well as for diesel and natural gas generators. This division markets its regenerating diesel particulate filters under the Purifilter, Combifilter, Purifier, Actifilter, and Cattrap brand names. The Catalyst division develops and produces catalysts to reduce emissions from gasoline, diesel, and natural gas combustion engines. This division's products include catalysts for gasoline and diesel engines, as well as for energy applications. Clean Diesel Technologies, Inc. sells its products through a network of dealers and distributors, as well as directly to original equipment manufacturers. The company was founded in 1996 and is headquartered in Oxnard, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Golden Stephen JohnChief Technology OfficerMay 19Sale2.485,51513,67428,204May 19 04:45 PM
Mehta Nikhil AtulOffice of CEO and CFOMay 19Sale2.486,23015,44738,324May 19 05:05 PM
Shea David EricVP Finance & Corp. ControllerMay 19Sale2.482,9407,2909,453May 19 05:44 PM
Harris Christopher JayChief Operating OfficerMay 19Sale2.484,35010,78612,933May 19 05:59 PM
Shea David EricVP Finance & Corp. ControllerMay 15Option Exercise0.006,694012,393May 19 05:44 PM
TickerESBF [NASD]
CompanyESB Financial Corp.
CountryUSA
IndustrySavings & Loans
Market Cap330.16MEPS (ttm)0.98
P/E18.97EPS this Y1.20%
Forward P/E-EPS next Y-
PEG-EPS past 5Y8.10%
P/S5.09EPS next 5Y-
P/B1.60EPS Q/Q13.00%
Dividend2.15%Sales Q/Q0.60%
Insider Own8.30%Inst Own15.50%
Insider Trans3.15%Inst Trans-0.18%
Short Float5.00%EarningsOct 14
Analyst Recom-Target Price-
Avg Volume25.28K52W Range11.46 - 14.55
30-Oct-14 06:02PMNasdaq stocks posting largest volume increases AP
30-Oct-14 06:02PMNasdaq stocks posting largest percentage increases AP
30-Oct-14 04:50PMSHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of ESB Financial Corp. in Connection with the Sale of the Company -ESBF PR Newswire
30-Oct-14 03:10PMINVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of ESB Financial Corp. Regarding the Fairness of the Sale of the Company to WesBanco Inc. Business Wire
30-Oct-14 01:21PMEQUITY ALERT: The Rosen Law Firm Announces Investigation of ESB Financial Corp. Concerning its Proposed Sale to WesBanco Inc. ESBF Business Wire
30-Oct-14 07:17AMESB FINANCIAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal O EDGAR Online
29-Oct-14 05:09PMWesBanco, Inc. Furthers Expansion into Pittsburgh Market; Announces Agreement and Plan of Merger with ESB Financial Corporation Business Wire
29-Oct-14 05:00PMWesBanco, Inc. Furthers Expansion into Pittsburgh Market; Announces Agreement and Plan of Merger with ESB Financial Corporation PR Newswire
21-Oct-14 04:44PMESB FINANCIAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi EDGAR Online
21-Oct-14 04:30PMESB Financial Corporation Announces Increased Third Quarter Earnings Business Wire
ESB Financial Corporation operates as a thrift holding company for ESB Bank that provides various retail and commercial financial products and services in western Pennsylvania, the United States. It offers various deposit products, including regular savings accounts, checking and money market accounts, certificate accounts, and time deposits. The company also provides single-family and multi-family residential mortgage loans; construction loans; commercial real estate loans; commercial business loans, including credit cards; and consumer loans, such as loans secured by deposit accounts, automobile loans, home equity loans, and secured and unsecured personal loans. In addition, it issues trust preferred securities to the public; and provides residential and commercial loan closing services, as well as title insurance services. Further, the company is engaged in the real estate development and construction of 1-4 family residential units. As of July 17, 2014, it operated 23 offices in Allegheny, Beaver, Butler, and Lawrence counties in Pennsylvania. ESB Financial Corporation was founded in 1915 and is headquartered in Ellwood City, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EVANOSKI CHARLES PGroup Sr VP/CFOOct 30Option Exercise10.085,76058,06193,786Oct 30 04:36 PM
PALKOVICH TODD FGroup Senior VP of LendingOct 30Option Exercise10.085,76058,06141,173Oct 30 04:37 PM
WADDING BONITA LYNNSr. VP/Controller/TreasurerOct 30Option Exercise10.082,25522,7303,526Oct 30 05:07 PM
ZUSCHLAG CHARLOTTE APresident and Chief ExecutiveOct 29Option Exercise10.089,92099,99497,148Oct 30 02:47 PM
MANNA MARIO JDirectorSep 16Option Exercise10.354,60847,69345,277Sep 16 12:43 PM
TickerOMER [NASD]
CompanyOmeros Corporation
CountryUSA
IndustryBiotechnology
Market Cap563.38MEPS (ttm)-1.59
P/E-EPS this Y12.60%
Forward P/E-EPS next Y56.30%
PEG-EPS past 5Y30.00%
P/S1126.76EPS next 5Y-
P/B-EPS Q/Q-10.40%
Dividend-Sales Q/Q-67.90%
Insider Own5.60%Inst Own41.90%
Insider Trans1.06%Inst Trans-0.20%
Short Float20.57%EarningsAug 11
Analyst Recom1.70Target Price32.80
Avg Volume340.24K52W Range6.92 - 18.80
30-Oct-14 08:26AM8:26 am Omeros granted pass-through reimbursement status from CMS Briefing.com
30-Oct-14 07:00AMOmidria Granted Pass-Through Reimbursement Status from CMS PR Newswire
23-Oct-14 03:10PMOmeros Falls as Enrollment for OMS824 Study is Suspended Zacks
22-Oct-14 06:52AMOmeros (OMER) Crumbles: Stock Tanks by 12.3% Zacks
21-Oct-14 08:23AMOmeros suspends mid-stage trial of Huntington's drug, shares fall Reuters
21-Oct-14 07:00AMOmeros Provides Update on PDE10 Inhibitor Program PR Newswire
07-Oct-14 07:00AMOMEROS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
29-Sep-14 04:46PMOMEROS CORP Files SEC form 8-K, Material Modification to Rights of Security Holders, Financial Statements and Exhibit EDGAR Online
15-Sep-14 06:57AMIncreased Earnings Estimates Seen for Omeros Corporation (OMER): Can It Move Higher? Zacks
19-Aug-14 01:04PMOMEROS CORP Financials EDGAR Online Financials
Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes products targeting inflammation, coagulopathies, and disorders of the central nervous system. Its clinical products include Omidria, which has completed two Phase III clinical trials for use during intraocular lens replacement, including cataract and other lens replacement surgery; OMS103 that is in Phase III clinical program for use during arthroscopic procedures, such as partial meniscectomy surgery; and OMS824, which is in Phase II clinical trial for the treatment of CNS disorders comprising schizophrenia and Huntington's disease. Its clinical programs also consist of OMS721 that is in Phase II clinical trial for the treatment of various complement-related diseases and disorders, including thrombotic microangiopathies; OMS405, which is in Phase II clinical trial for the treatment and prevention of addiction to substances of abuse; and OMS201 that has completed Phase 1/Phase 2 clinical trial for use during urological procedures, such as ureterscopy for removal of ureteral or renal stones. The company's preclinical products and development programs comprise OMS527 for the treatment of addiction and compulsive disorders, as well as for movement disorders, such as Parkinson's disease; and OMS616 for the control of blood loss during surgery, or resulting from trauma or other hyperfibrinolytic conditions. Its preclinical products also include G protein-coupled receptors platform for multiple disorders across therapeutic area; GPR17 for demyelinating disorders; and antibody platform for the discovery of monoclonal antibodies. Omeros Corporation was incorporated in 1994 and is based in Seattle, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cable Thomas J.DirectorSep 02Sale15.075,00075,33057,067Sep 04 08:00 PM
Demopulos Peter A MDDirectorJun 24Buy16.206,15399,704181,220Jun 24 07:00 PM
Demopulos Gregory A MDChairman, CEO & PresidentMay 18Option Exercise0.9820,00019,6001,526,822May 19 05:49 PM
Kelbon Marcia S.VP Patent and General CounselMay 16Option Exercise0.983,7743,699126,024May 19 05:52 PM
Cable Thomas J.DirectorMar 03Sale12.765,00063,81067,067Mar 05 04:05 PM
TickerTHTI [NASD]
CompanyTHT Heat Transfer Technology, Inc.
CountryChina
IndustryDiversified Machinery
Market Cap35.17MEPS (ttm)0.19
P/E9.05EPS this Y0.00%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-5.60%
P/S0.48EPS next 5Y-
P/B0.55EPS Q/Q150.00%
Dividend-Sales Q/Q16.50%
Insider Own24.90%Inst Own0.40%
Insider Trans-47.24%Inst Trans-184.53%
Short Float0.01%EarningsMar 31
Analyst Recom-Target Price-
Avg Volume80.08K52W Range0.78 - 2.84
15-Oct-14 04:33PM3 Industrial Stocks Pushing Industry Growth at TheStreet
15-Sep-14 01:40PMTHT HEAT TRANSFER TECHNOLOGY, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
22-Aug-14 01:04PMTHT HEAT TRANSFER TECHNOLOGY, INC. Financials EDGAR Online Financials
14-Aug-14 05:03PMTHT HEAT TRANSFER TECHNOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD D EDGAR Online
14-Aug-14 04:01PMTHT Heat Transfer Technology, Inc. Announces Second Quarter 2014 Results PR Newswire
17-Jul-14 04:02PM3 Stocks Pushing The Industrial Industry Lower at TheStreet
10-Jun-14 11:11AMTHT Heat Transfer Technology Inc Stock Downgraded (THTI) at TheStreet
15-May-14 04:13PMTHT HEAT TRANSFER TECHNOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD D EDGAR Online
15-May-14 04:01PMTHT Heat Transfer Technology, Inc. Announces First Quarter 2014 Results PR Newswire
31-Mar-14 04:07PMTHT HEAT TRANSFER TECHNOLOGY, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD D EDGAR Online
THT Heat Transfer Technology, Inc., through its subsidiaries, manufactures and trades in plate heat exchangers and various related products in the People's Republic of China. The company primarily offers plate heat exchangers, heat exchanger units, air-cooled heat exchangers, shell-and-tube heat exchangers, welded plate heat exchangers, and plate-and-shell heat exchangers. Its products are used for various applications in iron, steel, and aluminum manufacturing; chemical manufacturing; electric and nuclear power generation; central building air-conditioning; pharmaceutical production; food and beverage industry; high-pressure liquids; thermal power plants and residential heating systems; and in the equipment used in oil refining, the chemical industry, fertilizer production, and metallurgy. The company markets its products directly through its sales force. THT Heat Transfer Technology, Inc. is headquartered in Siping, the People's Republic of China.
TickerNXTD [NASD]
CompanyNxt-ID, Inc.
CountryUSA
IndustrySecurity & Protection Services
Market Cap60.62MEPS (ttm)-0.22
P/E-EPS this Y-600.00%
Forward P/E-EPS next Y50.00%
PEG-EPS past 5Y0.00%
P/S-EPS next 5Y-
P/B125.50EPS Q/Q-900.00%
Dividend-Sales Q/Q-
Insider Own41.60%Inst Own-
Insider Trans-11.35%Inst Trans-
Short Float10.39%Earnings-
Analyst Recom2.00Target Price6.00
Avg Volume752.96K52W Range1.36 - 5.90
31-Oct-14 06:04AMNXT-ID, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant EDGAR Online
27-Oct-14 09:00AMMedia Alert; NXT-ID Chief Technology Officer Comments on Why You Need a Smart Wallet PR Newswire
20-Oct-14 08:15AMMedia Alert; NXT-ID Chief Technology Officer Comments on Technology Differentiation of Wocket vs. Apple Pay PR Newswire
16-Oct-14 08:00AMNXT-ID Inc. to Present at 13th Annual FiRe Conference PR Newswire
15-Oct-14 04:32PMNXT-ID, INC. Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Non-Reliance on Previous Financials, EDGAR Online
15-Oct-14 08:00AMPhoto Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th PR Newswire
13-Oct-14 01:38PMAward Winning Producer and Investor Chad A. Verdi Rings NASDAQ Opening Bell With NXT-ID Team Marketwired
11-Oct-14 08:55AM13 Analyst Stocks Under $10 With Major Upside Calls at 24/7 Wall St.
10-Oct-14 06:00AMNXT-ID Inc. (Nasdaq: NXTD) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
09-Oct-14 08:00AMNXT-ID Inc. to Ring the Opening Bell of the NASDAQ Stock Market October 13th PR Newswire
Nxt-ID, Inc., a technology company, provides various biometric solutions. The company develops Wocket, a physical electronic wallet that is intended to hold information from credit cards, identification cards, and virtually any magnetic stripe card to allow a specific owner of the card to configure a single electronic card to replicate any of the copied cards; MobileBio VoiceMatch, a method of recognizing speakers and specific words providing multi-factor recognition; and FaceMatch that is intended to serve as a modular facial recognition system for smartphones, tablets, laptop, and desktop computers. It also offers 3D FaceMatch Biometric Identity System, an identity management platform providing fusion of 3D facial recognition, 2D facial recognition, and optional fingerprint biometrics; and 3D SketchArtist, a 3D software face composite sketch tool that makes sketching a face. The company's provides its solutions for securing mobile platforms, as well as for access control and law enforcement facial recognition markets. Nxt-ID, Inc. was founded in 2011 and is headquartered in Shelton, Connecticut.
TickerABMD [NASD]
CompanyABIOMED, Inc.
CountryUSA
IndustryMedical Appliances & Equipment
Market Cap1.27BEPS (ttm)0.17
P/E184.41EPS this Y-51.40%
Forward P/E65.45EPS next Y295.87%
PEG8.58EPS past 5Y17.10%
P/S6.68EPS next 5Y21.50%
P/B7.38EPS Q/Q0.00%
Dividend-Sales Q/Q14.30%
Insider Own2.60%Inst Own-
Insider Trans7.57%Inst Trans-0.01%
Short Float17.68%EarningsOct 30/b
Analyst Recom2.00Target Price28.38
Avg Volume242.00K52W Range20.29 - 30.77
30-Oct-14 06:02PMNasdaq stocks posting largest percentage increases AP
30-Oct-14 05:20PMOcwen Financial Climbs Despite Earnings Shortfall at TheStreet
30-Oct-14 08:49AMABIOMED INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
30-Oct-14 08:28AMAbiomed tops Street 2Q forecasts AP
30-Oct-14 07:21AM7:21 am Abiomed misses by $0.04, beats on revs; raises lower end of FY15 guidance, above consensus Briefing.com
30-Oct-14 07:07AMQ2 2015 Abiomed Inc Earnings Release - Before Market Open CCBN
30-Oct-14 07:00AMAbiomed Announces Second Quarter Fiscal 2015 Revenue of $51.9 Million, Up 17% Over Prior Year GlobeNewswire
09-Oct-14 02:41PMAbiomed Second Quarter Fiscal 2015 Earnings and Conference Call Notification GlobeNewswire
18-Sep-14 04:02PMABIOMED Up on Positive Impella RP Clinical Trial Results Zacks
18-Sep-14 10:10AMAbiomed Appoints Ingrid Goldberg as Director of Investor Relations GlobeNewswire
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor program. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Howley Michael GVP, Global Sales & MarketingApr 27Sale24.752,01649,89659,784Apr 30 03:08 PM
MINOGUE MICHAEL RPresident, CEO, ChairmanJul 28Option Exercise13.5725,411344,827243,622Jul 28 05:22 PM
MINOGUE MICHAEL RPresident, CEO, ChairmanJul 28Sale26.3025,411668,312218,211Jul 28 05:22 PM
MINOGUE MICHAEL RPresident, CEO, ChairmanJul 25Option Exercise13.5751,147694,065269,358Jul 28 05:22 PM
MINOGUE MICHAEL RPresident, CEO, ChairmanJul 25Sale26.3051,1471,345,171218,211Jul 28 05:22 PM
TickerLAKE [NASD]
CompanyLakeland Industries Inc.
CountryUSA
IndustryMedical Instruments & Supplies
Market Cap79.89MEPS (ttm)-0.65
P/E-EPS this Y99.60%
Forward P/E-EPS next Y-
PEG-EPS past 5Y-15.10%
P/S0.86EPS next 5Y-
P/B1.80EPS Q/Q-112.30%
Dividend-Sales Q/Q-47.00%
Insider Own0.50%Inst Own27.30%
Insider Trans-0.19%Inst Trans-1.10%
Short Float42.74%EarningsDec 12/a
Analyst Recom3.00Target Price-
Avg Volume3.06M52W Range4.75 - 29.55
30-Oct-14 05:09PMMarkets Rally On Better Than Expected GDP; Dow Has Best Close In More Than A Month Benzinga
30-Oct-14 02:23PMLakeland Living Up to Production Promises at 24/7 Wall St.
30-Oct-14 12:48PMHazmat-suit makers shares jump on Ebola orders at MarketWatch
30-Oct-14 12:07PMLakeland suit demand explodes, DreamWorks dips & investors abandon Avon Yahoo Finance
30-Oct-14 10:38AMLakeland Soars As Ebola Hazmat Suit Orders Pour In at Investor's Business Daily
30-Oct-14 10:35AMHazmat suit maker Lakeland ramps up production AP
30-Oct-14 10:30AMLakeland Industries (LAKE) Stock Soars on Ebola Suit Orders at TheStreet
30-Oct-14 10:20AMLakeland (LAKE) Stock Soars 30% on Hazmat Suit Sales, Ebola Panic Zacks
30-Oct-14 09:54AMLAKELAND INDUSTRIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Def EDGAR Online
30-Oct-14 09:38AMHazmat Suit Company Shares Explode Business Insider
Lakeland Industries, Inc., together with its subsidiaries, manufactures and sells safety garments and accessories for the industrial protective clothing market worldwide. The company provides limited use/disposable protective clothing, such as coveralls, lab coats, shirts, pants, hoods, aprons, sleeves, and smocks; high-end chemical protective suits to provide protection from highly concentrated and hazardous chemical and biological toxins; and fire fighting and heat protective apparel, which is used for the maintenance of high temperature equipment, and for military and airport crash and rescue teams. It also offers reusable woven garments, including electrostatic dissipative apparel used in the pharmaceutical and automotive industries, clean room apparel to prevent human contamination in the manufacturing processes, flame resistant and fire resistant cotton coveralls used in chemical and petroleum plants and for wild land firefighting, and extrication suits for police and ambulance workers; flame retardant and reflective garments for use in the fire industry, utilities, industrial uniforms, and state departments of transportation; and gloves and sleeves that are used in the automotive, glass, metal fabrication, and food service industries. The company sells its products to a network of approximately 1,200 North American safety and mill supply distributors through a customer service group, regional sales managers, and independent sales representatives. Its products are used by industrial customers, such as integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, mortuaries, high technology electronics manufacturers, and scientific and medical laboratories, as well as federal, state, and local governmental agencies and departments. The company was founded in 1982 and is headquartered in Ronkonkoma, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RYAN CHRISTOPHER JAMESChief Executive OfficerAug 06Buy5.601,0005,596480,105Aug 07 12:06 PM
Bachelder Stephen MChief Operating OfficerDec 30Buy4.951,5007,42555,585Dec 31 09:38 AM
Bachelder Stephen MChief Operating OfficerDec 27Buy5.031,0005,02554,085Dec 31 09:38 AM
Bachelder Stephen MChief Operating OfficerDec 23Buy5.093,50017,81053,085Dec 30 03:20 PM
TickerCALX [NYSE]
CompanyCalix Inc.
CountryUSA
IndustryCommunication Equipment
Market Cap547.90MEPS (ttm)-0.40
P/E-EPS this Y40.70%
Forward P/E20.07EPS next Y92.81%
PEG-EPS past 5Y5.70%
P/S1.44EPS next 5Y20.00%
P/B2.02EPS Q/Q20.00%
Dividend-Sales Q/Q3.80%
Insider Own9.30%Inst Own65.80%
Insider Trans0.68%Inst Trans-3.27%
Short Float3.69%EarningsOct 29/a
Analyst Recom2.00Target Price13.33
Avg Volume339.29K52W Range7.12 - 10.92
30-Oct-14 05:20PMOcwen Financial Climbs Despite Earnings Shortfall at TheStreet
30-Oct-14 05:04AMCalix reports 3Q loss AP
29-Oct-14 04:30PMCalix Inc Earnings Call scheduled for 4:30 pm ET today CCBN
29-Oct-14 04:18PM4:18 pm Calix Networks beats by $0.01, beats on revs Briefing.com
29-Oct-14 04:13PMCALIX, INC Files SEC form 8-K, Results of Operations and Financial Condition EDGAR Online
29-Oct-14 04:02PMCalix Reports Third Quarter 2014 Financial Results Marketwired
29-Oct-14 07:07AMQ3 2014 Calix Inc Earnings Release - After Market Close CCBN
22-Oct-14 02:20PMCALIX, INC Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
22-Oct-14 09:00AMFormer AT&T EVP Kevin Peters Joins Calix Board of Directors Marketwired
21-Oct-14 04:00AMCalix E7 Delivers "fibredirect" Service for Businesses to Ireland's First Fiber Towns Marketwired
Calix, Inc. develops, markets, and sells broadband communications access systems and software for fiber and copper-based network architectures that enable communications service providers (CSPs) to transform their networks and connect to their residential and business subscribers. Its Unified Access portfolio includes main platforms and/or nodes, the B6 Ethernet service access nodes, the C7 multiservice, multiprotocol access platform, the E-Series Ethernet service access platforms and nodes, and the BLM1500 gigabit passive optical network access terminal. The company's platforms, nodes, and terminals also include P-Series and T-Series optical network terminals and residential gateways; and the Calix Management System, Entriview element management software, and Compass suite of value-added software applications. Its portfolio serves the CSP network from the central office or data center to the subscriber premises and enables CSPs to deliver basic voice and data, and broadband services over legacy and next-generation access networks. The company markets its access systems and software to communication service providers in the United States, the Caribbean, Europe, Canada, and internationally through its direct sales force and resellers. Calix, Inc. was founded in 1999 and is headquartered in Petaluma, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Russo CarlPresident & CEOSep 02Sale10.4625,000261,5003,210,924Sep 04 05:27 PM
Banta TonySVP, Global Mfg & SupplyAug 05Sale9.0427,300246,79210,000Aug 05 09:35 PM
Banta TonySVP, Global Mfg & SupplyAug 04Sale9.063,42631,04037,300Aug 05 09:35 PM
Russo CarlPresident & CEOJun 02Sale8.078,10065,3673,252,824Jun 04 09:04 PM
Russo CarlPresident & CEOMar 04Sale8.0125,000200,2503,260,924Mar 06 06:16 PM
TickerTROV [NASD]
CompanyTrovaGene, Inc.
CountryUSA
IndustryBiotechnology
Market Cap97.71MEPS (ttm)-0.53
P/E-EPS this Y21.30%
Forward P/E-EPS next Y-21.60%
PEG-EPS past 5Y0.00%
P/S325.71EPS next 5Y-
P/B5.62EPS Q/Q82.40%
Dividend-Sales Q/Q13.50%
Insider Own11.67%Inst Own21.20%
Insider Trans0.27%Inst Trans-1.98%
Short Float4.57%EarningsNov 10
Analyst Recom2.00Target Price9.00
Avg Volume166.15K52W Range2.97 - 7.10
29-Oct-14 08:10AMTrovagene Schedules Release of Third Quarter 2014 Financial Results and Investor Conference Call PR Newswire
27-Oct-14 08:10AMClinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery PR Newswire
06-Oct-14 04:30PMTrovagene to Present at 13th Annual BIO Investor Forum PR Newswire
03-Oct-14 06:00AMTROVAGENE, INC. Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
01-Oct-14 08:05AMClinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium PR Newswire
29-Sep-14 08:05AMTrovagene Expands Clinical Program with New Study Evaluating its Precision Cancer Monitoring Platform in Lung Cancer PR Newswire
18-Sep-14 04:00PMTROVAGENE, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
17-Sep-14 08:05AMCancer Geneticist, Alberto Bardelli, Ph.D., Joins Trovagene's Scientific Advisory Board PR Newswire
15-Sep-14 07:50AMCan The Uptrend Continue for TrovaGene (TROV)? Zacks
08-Sep-14 06:49AMIncreased Earnings Estimates Seen for TrovaGene (TROV): Can It Move Higher? Zacks
Trovagene, Inc., a development stage molecular diagnostic company, focuses on the development and commercialization of a proprietary urine-based molecular diagnostic technology. Its technology is used in the detection and monitoring of diseases in various medical disciplines, primarily the management of cancer treatment. The company's proprietary urine-based molecular diagnostic tests are used to detect cell-free DNA and RNA originating from normal and diseased cell death that can be isolated and detected from urine. Its technology is applied in various testing, such as tumor mutation detection and monitoring, infectious disease monitoring, transplantation monitoring, and prenatal genetic diagnostics. The company was formerly known as Xenomics, Inc. and changed its name to Trovagene, Inc. in January 2010. Trovagene, Inc. was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ZANIBONI STEVECFOJun 09Buy3.956,32925,0006,329Jun 10 03:59 PM
TickerCYOU [NASD]
CompanyChangyou.com Limited
CountryChina
IndustryMultimedia & Graphics Software
Market Cap1.25BEPS (ttm)2.32
P/E10.17EPS this Y81.80%
Forward P/E16.13EPS next Y795.20%
PEG-EPS past 5Y28.70%
P/S1.69EPS next 5Y-
P/B0.72EPS Q/Q-95.00%
Dividend-Sales Q/Q-2.50%
Insider Own7.76%Inst Own47.50%
Insider Trans-Inst Trans-0.47%
Short Float4.52%EarningsNov 03/b
Analyst Recom3.50Target Price21.86
Avg Volume142.05K52W Range17.13 - 34.32
29-Oct-14 07:29AMChangyou.com (CYOU) Soars: Stock Adds 13.7% in Session Zacks
20-Oct-14 01:00AMChangyou.com to Report Third Quarter 2014 Financial Results on November 3, 2014 PR Newswire
10-Sep-14 10:42PMForgame: Webgame Users Hard To Get, MS Downgrades at Barrons.com
29-Jul-14 02:05PMMorgan Stanley Lowers Price Targets On Two Chinese Media Stocks Benzinga
28-Jul-14 01:00AMChangyou Reports Second Quarter 2014 Unaudited Financial Results PR Newswire
25-Jul-14 11:39AMCitigroup Initiates Coverage On A Number Of Chinese Internet Stocks Benzinga
22-Jul-14 03:11PMMRFI and Changyou.com Are Two Undervalued Stocks in an Overvalued Market at TheStreet
22-Jul-14 01:46PM3 Stocks Near 52-Week Lows Worth Buying at Motley Fool
18-Jul-14 05:21AMChangyou.com appoints Rucia Ren as acting CFO at theflyonthewall.com
18-Jul-14 04:00AMChangyou Announces Appointment of Acting CFO PR Newswire
Changyou.com Limited develops and operates online games in the People's Republic of China. The company is primarily involved in the development, operation, and licensing of massively multi-player online games (MMOGs), which are interactive online games that might be played simultaneously by various game players; Web-based games, which are played over the Internet using a Web browser; and mobile games, which are played on mobile devices and require an Internet connection. The company operates various MMOGs that include Tian Long Ba Bu, Blade Online series, Duke of Mount Deer, Da Hua Shui Hu, Wartune, Dou Po Cang Qiong, and DDTank. It also owns and operates the 17173.com Website, a game information portal in China; 37wanwan.com Website, a games portal that provides a collection of Web games; and Raidcall, a communication software that is used by professionals and gamers. As of December 31, 2013, it had approximately 25 million total average monthly active accounts for games; and 149 million total average monthly active accounts for platform channels. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. Changyou.com Limited is a subsidiary of Sohu.com Inc.
1 2 3 4 5 6 ... 10 ... 19 next